Is CANF or CBIO more undervalued in 2026?

CirclFi compares Can-Fite Biopharma Ltd (CANF) and Crescent Biopharma, Inc. (CBIO) using 13 institutional-grade valuation models. CANF has a Quality of Company score of 2.2/10 while CBIO scores 5.3/10.

Which is a better buy — CANF or CBIO?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do CANF and CBIO valuations compare?

CANF at $3.36 and CBIO at $21.47 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

CANF vs CBIO Valuation Comparison 2026 — Intrinsic Value Analysis

CANF

Biotechnology

Can-Fite Biopharma Ltd

Quality

2.2

out of 10

Value Trap

SAFE

Price

$3.36

Last close

Models

9/13

Active

CBIO

Biotechnology

Crescent Biopharma, Inc.

Quality

5.3

out of 10

Value Trap

SAFE

Price

$21.47

Last close

Models

9/13

Active

Model-by-Model Comparison

Model	Type	CANF Fair Value	CANF Upside	CBIO Fair Value	CBIO Upside
Bayesian DCF	Intrinsic	$0.89	-73.5%	$8.97	-58.2%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.39	-88.5%	$4.01	-81.3%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$2.83	-15.6%	$19.45	-9.4%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for CANF vs CBIO — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

CANF vs CBIO — Which Stock Is More Undervalued?

CBIO scores higher with a 5.3/10 quality rating vs CANF's 2.2/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Can-Fite Biopharma Ltd (CANF) and Crescent Biopharma, Inc. (CBIO) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

CANF currently trades at $3.36 with a QOC of 2.2/10, while CBIO trades at $21.47 with a QOC of 5.3/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).